Global Point of Care
Global Point of Care
Omicron globally became the predominant SARS-CoV-2 variant in late 2021. Some studies have suggested Omicron has a different replication pattern that could affect detection by rapid antigen tests. Reports in social media have promulgated oral swabs as a superior sample for detecting Omicron in the early stage of infection compared to nasal swabs.
More recently, publications report detection of Omicron by rapid antigen tests is comparable to the Delta Variant and other previous variants.
Paul Drain, MD, MPH, Seattle Cancer Center Alliance (SCCA) and University of Washington, USA
“Global Considerations on Omicron Diagnostics”
Amilcar Tanuri, MD, PhD, University of Rio de Janeiro, BRAZIL
“Evaluation of Subjects Infected with Omicron Variant Using RT-PCR and Antigen RDT”
Mary Rodgers, PhD, Abbott, USA
“The Abbott Global Surveillance Program: Protecting Public Health Through Viral Molecular Surveillance”
Rajeeb Debray, MD, Abbott, UK
Pascal M. FREY, MsC, Bern University Hospital, SWITZERLAND
A Leader In Rapid Point-Of-Care Diagnostics.
©2024 Abbott. All rights reserved. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.
This website is governed by applicable U.S. laws and governmental regulations. The products and information contained herewith may not be accessible in all countries, and Abbott takes no responsibility for such information which may not comply with local country legal process, regulation, registration and usage.
Your use of this website and the information contained herein is subject to our Website Terms and Conditions and Privacy Policy. Photos displayed are for illustrative purposes only. Any person depicted in such photographs is a model. GDPR Statement
Not all products are available in all regions. Check with your local representative for availability in specific markets. For in vitro diagnostic use only. For i-STAT test cartridge information and intended use, refer to individual product pages or the cartridge information (CTI/IFU) in the i-STAT Support area.
Abbott - A Leader in Rapid Point-of-Care Diagnostics.